Skip to main content
. 2016 Oct 13;7(46):76108–76117. doi: 10.18632/oncotarget.12627

Table 1. ZNF703 expression and clinicopathological parameters of the 85 CCA patients.

Total ZES≤4 ZES≥6
Parameters n n (%) n (%) χ2 P-value
85 39 46
Age (years)
≤60 42 20(47.6) 22(52.4) 0.101 0.751
>60 43 19(44.2) 24(55.8)
Gender
Male 45 24(53.3) 21(46.7) 2.138 0.143
Female 40 15(37.5) 25(62.5)
Tumor location
Liver 65 32(49.2) 33(50.1) 9.674 0.002
Common bile duct 20 7(35.0) 13(65.0)
Tumor size (cm)
>3 59 23(38.9) 36(61.1) 3.698 0.054
≤3 26 16(61.5) 10(38.5)
Pathological grading
I-II 44 15(34.1) 29(65.9) 5.108 0.024
III-IV 41 24(58.5) 17(41.5)
Invasive depth
T0-T2 60 34(56.7) 26(43.3) 9.555 0.002
T3-T4 25 5(20.0) 20(80.0)
Lymph node invasion
Present 27 15(55.6) 12(44.4) 1.491 0.222
Absent 58 24(41.4) 34(58.6)
Distant metastasis
Present 7 0(0.00) 7(100.0) 6.467 0.011
Absent 78 39(50.0) 39(50.0)
AJCC TNM stages
I-II 60 22(36.7) 38(63.3) 6.978 0.008
III-IV 25 17(68.0) 8(32.0)